From: Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
Total (n = 152) | Initial dosing strategy of thromboprophylaxis | p-valued | |||
---|---|---|---|---|---|
Low dosea (n = 67) | Medium doseb (n = 48) | High dose c (n = 37) | |||
Primary outcome | |||||
28-day mortality, No. (%) | 43 (28.3) | 26 (38.8) | 12 (25.0) | 5 (13.5) | 0.02 |
Secondary outcomes | |||||
ICU-free days alive during 28 days from ICU-admission, days | 9 (0–21) | 0 (0–20) | 11 (0–19) | 18 (0–26) | 0.07 |
Thromboembolic events < 28 days, No. (%) | 22 (14.5) | 12 (17.9) | 9 (18.8) | 1 (2.7) | 0.04 |
Pulmonary embolism, No. (%) | 17 (11.2) | 10 (14.9) | 6 (12.5) | 1 (2.7) | 0.15 |
Deep vein thrombosis, No. (%) | 4 (2.6) | 1 (1.5) | 3 (6.3) | 0 (0.0) | 0.21 |
Ischemic stroke, No. (%) | 4 (2.7) | 4 (6.0) | 0 (0.0) | 0 (0.0) | 0.16 |
Other thrombotic event, No. (%) | 3 (2.0) | 2 (3.0) | 1 (2.1) | 0 (0.0) | 0.79 |
Time to event, days | 8 (6–17) | 8 (6–20) | 8 (6–10) | 11 (11–11) | 0.61 |
Bleeding events < 28 days, No. (%) | 16 (10.5) | 8 (11.9) | 7 (14.6) | 1 (2.7) | 0.16 |
Cerebral parenchymal bleeding, No. (%) | 2 (1.3) | 2 (3.0) | 0 (0.0) | 0 (0.0) | 0.50 |
WHO bleeding assessment score | |||||
Grade I—minor, No. (%) | 8 (5.3) | 3 (4.5) | 4 (8.3) | 1 (2.7) | 0.58 |
Grade II—moderate, No. (%) | 3 (2.0) | 2 (3.0) | 1 (2.1) | 0 (0.0) | 0.79 |
Grade III—major, No. (%) | 2 (1.3) | 1 (1.5) | 1 (2.1) | 0 (0.0) | 0.99 |
Grade IV—severe, No. (%) | 3 (2.0) | 2 (3.0) | 1 (2.1) | 0 (0.0) | 0.79 |
Time to bleeding event, days | 13 (8–18) | 16 (6–20) | 11 (10–20) | 1 (1–1) | 0.36 |
Lab characteristics | |||||
Fibrin-D-dimer, mg/L FEU, highest | 3.2 (1.2–9.9) | 6.4 (2.0–14.6) | 2.8 (1.2–9.4) | 1.7 (0.7–3.3) | 0.002 |
CRP, mg/L, highest | 282 (183–381) | 335 (200–423) | 290 (201–385) | 229 (162–319) | 0.01 |
Hemoglobin, g/L, lowest | 98 (85–113) | 94 (80–104) | 102 (94–116) | 107 (95–118) | 0.01 |
Creatinine, µmol/L, highest | 82 (64–158) | 100 (78–236) | 78 (55–139) | 66 (49–74) | < 0.001 |
Platelet count, 109/L, lowest | 239 (180–322) | 203 (164–282) | 257 (197–290) | 314 (218–370) | 0.003 |
INR, highest | 1.1 (1.0–1.2) | 1.1 (1.0–1.2) | 1.1 (1.0–1.2) | 1.0 (1.0–1.1) | 0.18 |